Fresh From $750M Settlement, Medinol To Pursue Further Royalties From Boston Scientific
“We're going to bring a patent infringement case. . . . It's going to cover the Liberte and other products of theirs that we say infringe on our intellectual property,” Rory Millson, an attorney with Cravath, Swaine & Moore, told Reuters.
Boston Scientific will launch its Taxus Liberte drug-coated stent in...
To view the full article, register now.